A New Side Effect of Intravitreal Dexamethasone Implant (Ozurdex®).

Erdem ErisGurkan ErdoganIrfan PerenteGokhan DemirBurcin Kepez YildizEbru Demet Aygit

Published in: Case reports in ophthalmological medicine (2017)

Dexamethasone implant, 0,7 mg (Ozurdex, Allergan, Inc., Irvine, CA, USA), is drug mostly used in the treatment of the diabetic macular edema and edema related to retinal vein occlusion. By reporting this case we aimed to report a new side effect of 0.7 mg intravitreal dexamethasone implant that has not been reported in the literature before.

Keyphrases

diabetic retinopathy
high dose
low dose
soft tissue
vascular endothelial growth factor
systematic review
age related macular degeneration
optical coherence tomography
adverse drug
emergency department
protein kinase
combination therapy